ArticleJAC-antimicrobial resistance2025

Successful outpatient parenteral antimicrobial therapy with rezafungin for chronic pulmonary aspergillosis: a case report and health economic assessment.

Sheonagh MacPhail Law et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.